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Abstract The five different rat somatostatin receptor subtypes 
(SSTR1-SSTR5) were coexpressed with a subunit of G-protein 
gated inwardly rectifying potassium channel (GIRK1) in 
Xenopus oocytes. SSTR2-SSTR5, but not SSTR1 coupled 
efficiently to the activation of GIRK currents when stimulated 
by SST14 or SST28. A comparison of the dose-response curves 
and of the maximum currents obtained indicates that SSTR2 
couples most efficiently to this effector, supporting the notion 
that SSTR2 is involved in activation of potassium conductances 
by SST in vivo. 
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1. Introduction 
The neuropeptide somatostatin occurs in two isoforms, 
SST14 and SST28, both of which are abundant in brain and 
numerous peripheral tissues [1]. The actions of these two ago-
nists are mediated by at least five different somatostatin re-
ceptor subtypes (SSTR1-SSTR5), which are all coupled to 
G-proteins of the pertussis toxin sensitive G;/G0 class. In het-
erologous expression systems it has been shown that, depend-
ent on the cellular environment, these receptors can be 
coupled to the inhibition of adenylyl cyclase [2] and voltage-
dependent calcium channels [3], the activation of tyrosine 
phosphatases [4], phospholipase С [5] and of a phospholipase 
A2 [6]. In addition, it has frequently been observed in neuro-
nal and neuroendocrine cells that SST leads to the hyperpolar-
ization of the cell membrane by activation of G-protein gated 
inwardly rectifying potassium (GIRK) channels [7]. The acti-
vation of G I R K channels by somatostatin in pituitary cells is 
mainly responsible for the inhibitory effect of SST on growth 
hormone release [8]. Whereas recently strong evidence was 
provided that in oligodendrocytes SSTR1 is involved in the 
inhibition of potassium currents [9], it has been unclear so far 
which of the known SSTR subtypes mediates the activation of 
G I R K currents. Here we describe the coexpression of S S T R 1 -
SSTR5 together with the G I R K 1 subunit in Xenopus oocytes. 
We observed strong activation of inward potassium currents 
by SST14 in cells coexpressing G I R K 1 and either SSTR2, 
SSTR3, SSTR4, or SSTR5, but not SSTR1. 
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2. Materials and methods 
cDNAs coding for the rat somatostatin receptors SSTR1-SSTR5 
were cloned into the mammalian expression vector pcDNA3. A 
cDNA coding for the mouse GIRK1 subunit, also in pcDNA3, was 
obtained from Volker Höllt (Magdeburg). Plasmids were linearized 
with Xba\ (SSTR1-SSTR5) or Xho\ (GIRK1), and RNA was tran-
scribed in vitro using T7 RNA polymerase (Fermentas, Vilnius, 
Lithuania). 
Somatostatin receptor and GIRK1 cRNAs were mixed in a 1:1 
ratio and injected at a concentration of 80 ng/μΐ total RNA into 
Xenopus laevis oocytes [10]. Oocytes were kept in Barth medium for 
2 to 4 days at 20°C. For recordings, oocytes were superfused with 
ND-96 medium (96 mM NaCl, 2 mM KC1, 2.5 mM CaCl2, 1 mM 
MgS04 , 5 mM HEPES, pH 7.5) and clamped at - 8 0 mV. For meas-
urements of somatostatm agonists, the medium was changed to high 
K+ medium (hK, ND-96 with 96 mM KC1 and 2 mM NaCl); after 
the initial inward current reached a plateau, agonists were applied in 
the same medium. After washout of the agonists with hK, 300 μΜ 
ВаОг in hK was applied to determine the contribution of GIRK1-
mediated currents to the total inward current observed. 
3. Results and discussion 
The individual rat somatostatin receptor subtypes S S T R 1 -
SSTR5 were coexpressed together with G I R K 1 in Xenopus 
oocytes. Stimulation of these oocytes with somatostatinergic 
agonists in h K medium under voltage-clamp conditions re-
sulted in robust inward currents in cells expressing either 
rSSTR2, rSSTR3, rSSTR4 or rSSTR5 (Fig. 1). The peak cur-
rent amplitude was usually several hundred nA at an agonist 
concentration of 100 n M SST14 or 100 n M SST28. The larg-
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Fig. 1. Activation of inward potassium currents by SSTR subtypes. 
Xenopus oocytes injected with cRNA for the mouse GIRK1 subunit 
and rat somatostatin receptors were superfused with ND-96 medium 
and clamped at —80 mV. Open arrow, switch to hK medium; filled 
arrows, application of 100 nM SST14 (SSTR1-SSTR4) or 100 nM 
SST28 (SSTR5); upward filled arrows, washout with hK; upward 
open arrows, block of GIRK1 currents with 300 μΜ ВаСЬ. Insert: 
Oocyte injected with SSTR4 only. 
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est currents were reproducibly observed with SSTR2, with 
peak amplitudes often reaching values larger than 1 μΑ. 
SSTR2 was also efficiently activated by the stable somatosta-
tin analog SMS 201-995, whereas none of the SSTRs could be 
activated by the newly discovered SST-like compound TT232 
[11] at concentrations up to 1 μΜ (data not shown). In con-
trast to the other SSTRs, little or no inward current was 
observed upon stimulation of oocytes expressing SSTR1 and 
GIRK1 with SST14 or SST28. 
Whereas the currents rapidly returned to baseline levels 
after washout of the agonist in cells expressing SSTR2, 
SSTR3 or SSTR5, currents elicited by activation of SSTR4 
were relatively persistent and declined only slowly after wash-
out of the agonist. This may be related to the observation that 
SSTR4 does not exhibit agonist-induced functional desensiti-
zation (Kreienkamp et al., manuscript in preparation). 
No current was observed in oocytes expressing SSTR sub-
types (e.g. SSTR4) in the absence of the GIRK1 subunit, 
suggesting that the current observed is due to the activation 
of the coexpressed GIRK1 (Fig. 1). This interpretation is 
supported by the observation that the currents were sensitive 
to block by 300 μΜ ВаСЬ, a feature which is typical for 
GIRK-type channels [12]. As expected for an inward rectifier, 
agonist-induced currents were only observed in medium con-
taining high external potassium concentrations, but not in 
ND-96 medium. 
We investigated the dose-response relationship for activa-
tion of GIRK1 currents by the two naturally occurring soma-
tostatin derivatives, i.e. SST14 and SST28. SSTR2, SSTR3 
and SSTR4 showed a slight preference for SST14 over 
SST28, whereas the contrary was true for SSTR5, which 
was activated more efficiently by SST28 than by SST14 
(Fig. 2, Table 1). In comparison with the other receptor sub-
types, SSTR2 is by far the most efficient receptor in activating 
the GIRK-mediated current. The EC50 value for activation of 
this subtype by SST14 is about one order of magnitude lower 
than that observed for SSTR3 and SSTR4 (Fig. 2). 
The data reported here clearly show that four out of the five 
somatostatin receptor subtypes identified so far are able to 
activate G-protein gated inwardly rectifying potassium cur-
rents. One remarkable exception is SSTR1 which did not 
couple to GIRK1 in our oocyte system. GIRK activation 
by G-proteins has been shown to occur via interaction of 
the free βγ-subunits with the potassium channel proteins 
[13]. As dissociation of βγ-subunits from the G-protein heter-
otrimer is a step common to the signal transduction by all 
G-protein coupled receptors, it remains unclear how coupling 
specificity as observed here might arise. One potential mech-
anism was recently elucidated by Schreibmayer et al. [14], who 
showed that several activated Ga-subunits inhibited GIRK 
Table 1 
EC50 values for activation of GIRK1 currents by SSTR2-SSTR5 
using various SST agonists 
Receptor subtype SST14 SST28 
SSTR2 4.19 nM 23.5 nM 
SSTR3 54 nM 187 nM 
SSTR4 56 nM 104 nM 
SSTR5 290 nM 120 nM 
The data were obtained from the non-linear regression analysis of the 
dose-response curves presented in Fig. 2. 
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Fig. 2. Dose-response curves for activation of GIRK1 currents by 
SST14 and SST28. Peak currents were recorded from oocytes in-
jected with the appropriate cRNAs and stimulated with various con-
centrations of agonist. Between applications a minimum of 15 min 
delay time was observed to avoid desensitization of SSTRs or 
GIRK1 channels. The data were normalized to the maximum re-
sponse obtained from each oocyte and analyzed by non-linear re-
gression using the GraphPad Prizm software (GraphPad, San Diego, 
CA). 3 to 6 oocytes were analyzed per receptor/ligand combination, 
and the data are presented as the mean +/— standard error. Open 
circles, SST14; filled circles, SST28. 
channels activated by βγ. SSTR1 might therefore be coupled 
to one of these G-protein α-subunits in Xenopus oocytes. Al-
ternatively, another GIRK subunit might be necessary for 
SSTR1 to be effective. In agreement with our results, it was 
recently observed that in oligodendrocytes SSTR1 inhibits in-
wardly rectifying potassium currents [9]. 
SSTR2 appears to be the receptor subtype that activates 
GIRK most efficiently. SSTR2 is coupled to Gai3- and Gao-
subunits [15], and it was shown recently that Gai3 mediates the 
somatostatin-induced activation of GIRK currents in growth 
hormone secreting adenoma cells [16]. Thus it becomes very 
likely that SSTR2 is responsible for this effect in these cells. 
On the other hand, SSTR3 is likely to be the receptor subtype 
that mediates activation of GIRK channels by somatostatin 
observed in cerebellar granule cells [17], as SSTR3 is prom-
inently expressed in this brain region [18]. The lower EC50 
value for activation of SSTR5 by SST28 is in agreement 
with the higher affinity of this receptor subtype for the long 
SST isoform as determined in competition binding experi-
ments [19]. 
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